Intrexon Loss Narrows - Quick Facts

(RTTNews) - Intrexon Corp. (XON), the synthetic biology company, said Thursday its second-quarter net loss to common stockholers narrowed to $14 million or $2.46 per share from $22 million or $3.99 per share last year.

Revenue for the quarter climbed to $6.8 million from $2.7 million a year ago.

Research and development expenses decreased to $13.6 million from $17.rmillion in the prior year.

In August, Intrexon completed an initial public offering which resulted in aggregate proceeds to the company of about $168 million.

The company's stock closed Thursday at $23.70, down $0.60 or 2.47%, on a volume of 166 thousand shares on the NYSE.